Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis

Transplant Proc. 1994 Dec;26(6):3622-3.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use
  • Drug Administration Schedule
  • Graft Rejection / epidemiology
  • Graft Survival*
  • Hepatitis B / complications*
  • Hepatitis B Surface Antigens / blood*
  • Humans
  • Immunosuppression / methods*
  • Liver Failure / etiology
  • Liver Failure / surgery*
  • Liver Transplantation / immunology
  • Liver Transplantation / mortality
  • Liver Transplantation / physiology*
  • Postoperative Complications / epidemiology
  • Prednisolone / therapeutic use
  • Receptors, Interleukin-2 / immunology
  • Recurrence
  • Reoperation / statistics & numerical data
  • Retrospective Studies
  • Survival Rate
  • Tacrolimus / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Hepatitis B Surface Antigens
  • Receptors, Interleukin-2
  • Cyclosporine
  • Prednisolone
  • inolimomab
  • Azathioprine
  • Tacrolimus